Achondroplasia

Best Practice and Research: Clinical Rheumatology

Volumn 22, Issue 1, 2008, Pages 3-18

  Baujat, Geneviève ^a   Legeai Mallet, Laurence ^a   Finidori, Georges ^a   Cormier Daire, Valérie ^a   Le Merrer, Martine ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

achondroplasia; clinical features; differential diagnosis; management; molecular pathogenesis

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; HUMAN GROWTH HORMONE;

ACHONDROPLASIA; AUTOSOMAL DOMINANT DISORDER; BODY WEIGHT; BONE DYSPLASIA; CLINICAL TRIAL; COGNITIVE DEVELOPMENT; CONDUCTION DEAFNESS; COUNSELING; FAMILY; GENE MUTATION; HUMAN; INCIDENCE; LORDOSIS; MIDFACE HYPOPLASIA; PATIENT CARE; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RADIODIAGNOSIS; REVIEW; SHORT STATURE; SPINAL CORD COMPRESSION;

ACHONDROPLASIA; DIAGNOSIS, DIFFERENTIAL; GENETIC COUNSELING; HUMANS; MAGNETIC RESONANCE IMAGING; PRENATAL DIAGNOSIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3;

EID: 40149087703     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2007.12.008     Document Type: Review

References (70)

1. Maroteaux P, Le Merrer M. L'achondroplasie. In: Maladies Osseuses de l'Enfant. 4th edn. Paris, 2002, pp. 56-65.
2. Oberklaid F., Danks D.M., Jensen F., et al. Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine. Journal of Medical Genetics 16 (1979) 140-146
3. Orioli I.M., Castila E.E., Scarano G., and Mastroiacovo P. Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta. American Journal of Medical Genetics 59 (1995) 209-217
4. Stoll C., Dott B., Roth M.P., and Alembik Y. Birth prevalence rates of skeletal dysplasias. Clinical Genetics 35 (1989) 88-92
5. Martinez-Frias M.L., Cereijo A., Bermejo E., et al. Epidemiological aspects of Mendelian syndromes in a Spanish population sample: II. Autosomal dominant malformation syndromes. American Journal of Medical Genetics 38 (1991) 622-625
6. Dakouane Giudicelli M., Serazin V., Le Sciellour C.R., et al. Increased achondroplasia mutation frequency with advanced age and evidence for G1138A mosaicism in human testis biopsies. Fertility and Sterility 11 (2007) [Epub ahead of print]
7. Cordone M., Lituania M., Bocchino G., et al. Ultrasonographic features in a case of heterozygous achondroplasia at 25 weeks' gestation. Prenatal Diagnosis 13 (1993) 395-401
8. Mesoraca A., Pilu G., Perolo A., et al. Ultrasound and molecular mid-trimester prenatal diagnosis of de novo achondroplasia. Prenatal Diagnosis 16 (1996) 764-768
9. Krakow D., Williams III J., Poehl M., et al. Use of three-dimensional ultrasound imaging in the diagnosis of prenatal-onset skeletal dysplasias. Ultrasound in Obstetrics & Gynecology 21 (2003) 467-472
10. Ruano R., Molho M., Roume J., and Ville Y. Prenatal diagnosis of fetal skeletal dysplasias by combining two-dimensional and three-dimensional ultrasound and intrauterine three-dimensional helical computer tomography. Ultrasound in Obstetrics & Gynecology 24 (2004) 134-140
11. Trotter T.L., and Hall J.G. American Academy of Pediatrics Committee on Genetics. Health supervision for children with achondroplasia. Pediatrics 116 (2005) 771-783
12. Horton W.A., Rotter J.I., Rimoin D.L., et al. Standard growth curves for achondroplasia. The Journal of Pediatrics 93 (1978) 435-438
13. Taybi H., and Lachman R. Achondroplasia. Radiology of syndromes, metabolic disorders and skeletal dysplasias. 4th edn. (2000), CV Mosby 749-755
14. Horton W.A., Hall J.G., and Hecht J.T. Achondroplasia. Lancet 370 (2007) 162-172
15. Hunter A.G.W., Bankier A., Rogers J.G., et al. Medical complications of achondroplasia: a multicentre patient review. Journal of Medical Genetics 35 (1998) 705-712
16. Carter E.M., Davis J.G., and Raggio C.L. Advances in understanding etiology of achondroplasia and review of management. Current Opinion in Pediatrics 19 (2007) 32-37
17. Bruhl K., Stoeter P., Wietek B., et al. Cerebral spinal fluid flow, venous drainage and spinal cord compression in achondroplastic children: impact of magnetic resonance findings for decompressive surgery at the cranio-cervical junction. European Journal of Pediatrics 160 (2001) 10-20
18. Hecht J.T., Horton W.A., Reid C.S., et al. Growth of the foramen magnum in achondroplasia. American Journal of Medical Genetics 32 (1989) 528-535
19. Pierre-Kahn A., Hirsch J.F., Renier D., et al. Hydrocephalus and achondroplasia. A study of 25 observations. Child's Brain 7 (1980) 205-219
20. Reid C.S., Pyeritz R.E., Kopits S.E., et al. Cervicomedullary compression in young patients with achondroplasia: value of comprehensive neurologic and respiratory evaluation. The Journal of Pediatrics 110 (1987) 522-530
21. Ryken T.C., and Menezes A.H. Cervicomedullary compression in achondroplasia. Journal of Neurosurgery 81 (1994) 43-48
22. Bagley C.A., Pindrik J.A., Bookland M.J., et al. Cervicomedullary decompression for foramen magnum stenosis in achondroplasia. Journal of Neurosurgery 104 (2006) 166-172
23. Rimoin D.L. Cervicomedullary junction compression in infants with achondroplasia: when to perform neurosurgical decompression. American Journal of Human Genetics 56 (1995) 824-827
24. Ho N.C., Guarnieri M., and Brant L.J. Living with achondroplasia: quality of life evaluation following cervico-medullary decompression. American Journal of Medical Genetics. Part A 131 (2004) 163-167
25. Boor R., Fricke G., Brühl K., and Spranger J. Abnormal subcortical somatosensory evoked potentials indicate high cervical myelopathy in achondroplasia. European Journal of Pediatrics 158 (1999) 662-667
26. Sciubba D.M., Noggle J.C., Marupudi N.I., et al. Spinal stenosis surgery in pediatric patients with achondroplasia. Journal of Neurosurgery 106 (2007) 372-378
27. Pauli R.M., Breed A., Horton V.K., et al. Prevention of fixed, angular kyphosis in achondroplasia. Journal of Pediatric Orthopedics 7 (1997) 726-733
28. Kopits S.E. Correction of bowleg deformity in achondroplasia. The Johns Hopkins Medical Journal 146 (1980) 206-209
29. Pauli R.M., Scott C.I., Wassman Jr. E.R., et al. Apnea and sudden unexpected death in infants with achondroplasia. The Journal of Pediatrics 104 (1984) 342-348
30. Hecht J.T., Francomano C.A., Horton W.A., and Annegers J.F. Mortality in achondroplasia. American Journal of Human Genetics 41 (1987) 454-464
31. Waters K.A., Everett F., Sillence D.O., et al. Treatment of obstructive sleep apnea in achondroplasia: evaluation of sleep, breathing, and somatosensory-evoked potentials. American Journal of Medical Genetics 59 (1995) 460-466
32. Tasker R.C., Dundas I., Laverty A., et al. Distinct patterns of respiratory difficulty in young children with achondroplasia: a clinical, sleep, and lung function study. Archives of Disease in Childhood 79 (1998) 99-108
33. Hecht J.T., Hood O.J., Schwartz R.J., et al. Obesity in achondroplasia. American Journal of Medical Genetics 31 (1988) 597-602
34. Wynn J., King T.M., Gambello M.J., et al. Mortality in achondroplasia study: a year follow-up. American Journal of Medical Genetics. Part A 143 (2007) 2502-2511
35. Gardner R.J.M. A new estimate of the achondroplasia mutation rate. Clinical Genetics 11 (1977) 31-38
36. Le Merrer M., Rousseau F., Legeai-Mallet L., et al. A gene for achondroplasia-hypochondroplasia maps to chromosome 4p. Nature Genetics 6 (1994) 318-321
37. Velinov M., Slaugenhaupt S.A., Stoilov I., et al. The gene for achondroplasia maps to the telomeric region of chromosome 4p. Nature Genetics 6 (1994) 314-317
38. Rousseau F., Bonaventure J., and Legeai-Mallet L. Clinical and genetic heterogeneity of hypochondroplasia. Journal of Medical Genetics 33 (1996) 749-752
39. Shiang R., Thompson L.M., Zhu Y.Z., et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78 (1994) 335-342
40. Bellus G.A., Hefferon T.W., Ortiz de Luna R.I., et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. American Journal of Human Genetics 56 (1995) 368-373
41. Opitz J.M. Editorial comment: unstable premutation in achondroplasia: penetrance vs phenotrance. American Journal of Medical Genetics 19 (1984) 251-254
42. Philip N., Auger M., Mattei J.F., and Giraud F. Achondroplasia in sibs of normal parents. Journal of Medical Genetics 5 (1988) 857-859
43. Fryns J.P., Kleczkowska A., Verresen H., and van den Berghe H. Germinal mosaicism in achondroplasia: a family with 3 affected siblings of normal parents. Clinical Genetics 24 (1983) 156-158
44. Mettler G., and Fraser F.C. Recurrence risk for sibs of children with 'sporadic' achondroplasia. American Journal of Medical Genetics 90 (2000) 250-251
45. Murdoch J.L., Walker B.A., Hall J.G., et al. Achondroplasia, a genetic and statistical survey. Annals of Human Genetics 33 (1970) 227-244
46. Wilkin D.J., Szabo J.K., Cameron R., et al. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. American Journal of Medical Genetics 63 (1998) 711-716
47. Goriely A., McVean G.A., van Pelt A.M., et al. Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 6051-6056
48. Bellus G.A., McIntosch I., Smith A.E., et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nature Genetics 10 (1995) 357-359
49. Grigelioniene G., Eklof O., Laurencikas E., et al. L.Asn540Lys mutation in fibroblast growth factor receptor 3 and phenotype in hypochondroplasia. Acta Paediatrica 89 (2000) 1072-1076
50. Bellus G.A., Spector E.B., Speiser P.W., et al. Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. American Journal of Human Genetics 67 (2000) 1411-1421
51. Winterpacht A., Hilbert K., Stelzer C., et al. A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia. Physiological Genomics 2 (2000) 9-12
52. Stoilov I., Kilpatrick M.W., and Tsipouras P. A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia. American Journal of Human Genetics 55 (1995) 127-133
53. Vajo Z., Francomano C.A., and Wilkin D.J. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocrine Reviews 21 (2000) 23-39
54. Tavormina P.L., Bellus G.A., and Webster M.K. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. American Journal of Human Genetics 64 (1999) 722-731
55. Rousseau F., Bonaventure J., Le Merrer M., et al. Mutations of FGFR3 gene cause 3 types of nanisms with variably severity: achondroplasia, thanatophoric nanism and hypochondroplasia. Annales d'endocrinologie (Paris) 57 (1996) 153
56. Muenke M., Gripp K.W., McDonald-McGinn D.M., et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. American Journal of Human Genetics 60 (1997) 555-564
57. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103 (2000) 211-225
58. Pejchalova K, Krejci P, Wilcox WR. C-natriuretic peptide: an important regulator of cartilage. Molecular Genetics and Metabolism 92: 210-215.
59. Gibbs L., and Legeai-Mallet L. FGFR3 intracellular mutations induce tyrosine phosphorylation in the Golgi and defective glycosylation. Biochimica Et Biophysica Acta 1773 (2007) 502-512
60. Hafner C., van Oers J.M., Tb V., et al. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. The Journal of Clinical Investigation 116 (2006) 2201-2207
61. Gollust S.E., Thompson R.E., Gooding H.C., and Biesecker B.B. Living with achondroplasia: attitudes toward population screening and correlation with quality of life. Prenatal Diagnosis 23 (2003) 1003-1008
62. Horton W.A., Hecht J.T., Hood O.J., et al. Growth hormone therapy in achondroplasia. American Journal of Medical Genetics 42 (1992) 667-670
63. Shohat M., Tick D., Barakat S., et al. Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia. Journal of Clinical Endocrinology & Metabolism 81 (1996) 4033-4037
64. Seino Y., Yamanaka Y., Shinohanora M., et al. Growth hormone therapy in achondroplasia. Hormone Research 533 (2000) 53-56
65. Aldegheri R., Trivella G., Renzi-Brivio L., et al. Lengthening of the lower limbs in achondroplastic patients. A comparative study of four techniques. The Journal of Bone and Joint Surgery 70B (1988) 69-73
66. Lavini F., Renzi-Brivio L., and de Bastiani G. Psychologic, vascular, and physiologic aspects of lower limb lengthening inachondroplastics. Clinical Orthopaedics and Related Research 250 (1990) 138-142
67. Ganel A, Horoszowski H, Kamhin M, Farine I. Leg lengthening in achondroplastic children. 1979; 144: 194-197.
68. Rauchenberger R., Borges E., Thomassen-Wolf E., et al. Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3. The Journal of Biological Chemistry 278 (2003) 194-205
69. Yasoda A., Komatsu Y., Chusho H., et al. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Natural Medicines 101 (2004) 80-86
70. Benoist-Lasselin C., Gibbs L., Heuertz S., Odent T., Munnich A., and Legeai-Mallet L. Human immortalized chondrocytes carrying heterozygous FGFR3 mutations: an in vitro model to study chondrodysplasias. FEBS Letters 581 (2007) 2593-2598